Sort
23,748 grants matching “melanoma”
POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION
$590,392Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension
$590,163Laszlo Farkas · Ohio State University · R01 · FY2020 · HL
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
New tools for tracking single cells in vivo
$589,925Guillem Pratx · Stanford University · R01 · FY2024 · EB
Toward translation of a plant virus-based in situ vaccination nanotechnology
$589,872Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Skin Cancer Prevention in a Pediatric Population
$589,791University Of Colorado Denver · R01 · FY2005 · CA
Development of novel selective Rac inhibitors for refractory leukemias
$589,782David A Williams · Boston Children'S Hospital · R01 · FY2019 · CA
Redox imaging for breast cancer prognosis
$589,750Lin Z Li · University Of Pennsylvania · R01 · FY2019 · CA
Semantic Data Lake for Biomedical Research
$589,741Mansur R. Kabuka · Infotech Soft, Inc. · R44 · FY2017 · CA
Rational approaches to melanoma therapy
$589,729Meenhard Herlyn · Wistar Institute · U54 · FY2022 · CA
Communication Intervention with Melanoma Families
$589,674Deborah J. Bowen · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$589,637Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$589,231Ira O Daar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$589,231Ira Daar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
$589,162James R. Heath · California Institute Of Technology · R01 · FY2013 · CA
Developmental origins and homeostatic mechanisms underlying adult phenotypes
$589,160David M Parichy · University Of Virginia · R35 · FY2023 · GM
Developmental origins and homeostatic mechanisms underlying adult phenotypes
$589,160David M Parichy · University Of Virginia · R35 · FY2022 · GM
Developmental origins and homeostatic mechanisms underlying adult phenotypes
$589,160David M Parichy · University Of Virginia · R35 · FY2024 · GM
Developmental origins and homeostatic mechanisms underlying adult phenotypes
$589,160David M Parichy · University Of Virginia · R35 · FY2025 · GM
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
$589,090Joel J Hillhouse · East Tennessee State University · R01 · FY2011 · CA
Aim 2: Network-level modeling of single-agent and combination therapy
$588,967Peter Karl Sorger · Harvard Medical School · P50 · FY2018 · GM
New tools for tracking single cells in vivo
$588,962Guillem Pratx · Stanford University · R01 · FY2023 · EB
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy
$588,833Jun Wang · New York University School Of Medicine · R37 · FY2022 · CA
Illinois Oncology Research Association CCOP
$588,766Methodist Medical Center Of Illinois · U10 · FY2004 · CA